Figure 3.

Biomarker panel validation. (a) ROC curves for the optimal 6-miRNA biomarker panels used in distinguishing patients with breast cancer from those with benign breast nodule in the Discovery (left panel) and Validation cohort (right panel). (b) ROC curves for the optimal 6-miRNA biomarker panels used in distinguishing patients with breast cancer from those with benign breast lesions and normal mammograms. (c) Box and whiskers plots of 6-miRNA biomarker scores in differentiating breast cancers by tumor size, stage, and number of lymph nodes affected.